ProShare Advisors LLC Purchases 14,257 Shares of Corteva, Inc. $CTVA

ProShare Advisors LLC lifted its position in shares of Corteva, Inc. (NYSE:CTVA) by 10.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 146,416 shares of the company’s stock after acquiring an additional 14,257 shares during the period. ProShare Advisors LLC’s holdings in Corteva were worth $9,814,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Activest Wealth Management lifted its holdings in shares of Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after acquiring an additional 200 shares during the period. JPL Wealth Management LLC bought a new stake in shares of Corteva during the 3rd quarter worth approximately $25,000. Redmont Wealth Advisors LLC bought a new stake in shares of Corteva during the 3rd quarter worth approximately $29,000. Jackson Grant Investment Advisers Inc. lifted its holdings in shares of Corteva by 90.6% during the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after acquiring an additional 213 shares during the period. Finally, Measured Wealth Private Client Group LLC bought a new stake in shares of Corteva during the 3rd quarter worth approximately $33,000. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

Shares of NYSE:CTVA opened at $79.16 on Friday. The company has a market cap of $52.95 billion, a price-to-earnings ratio of 46.57, a PEG ratio of 2.41 and a beta of 0.59. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The firm has a 50 day simple moving average of $81.31 and a 200 day simple moving average of $73.92. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the prior year, the company posted $1.13 EPS. The company’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio is 42.35%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on CTVA shares. The Goldman Sachs Group increased their price objective on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, April 14th. Weiss Ratings raised shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. UBS Group increased their price objective on shares of Corteva from $88.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Royal Bank Of Canada increased their price objective on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Finally, CICC Research increased their price objective on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Thirteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.14.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.